Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.94M Sell
11,188
-6,876
-38% -$2.45M 0.21% 82
2025
Q4
$5.91M Buy
18,064
+814
+5% +$258K 0.26% 74
2025
Q3
$4.87M Sell
17,250
-120
-0.7% -$34.8K 0.21% 97
2025
Q2
$4.85M Sell
17,370
-1,052
-6% -$298K 0.24% 82
2025
Q1
$5.74M Sell
18,422
-38
-0.2% -$11.2K 0.31% 67
2024
Q4
$4.81M Buy
+18,460
New +$5.48M 0.26% 80
2023
Q1
Sell
-9,543
Closed -$2.51M 452
2022
Q4
$2.51M Buy
+9,543
New +$2.56M 0.36% 41
2022
Q2
Sell
-7,734
Closed -$1.87M 528
2022
Q1
$1.87M Buy
7,734
+3,498
+83% +$804K 0.18% 110
2021
Q4
$953K Buy
4,236
+265
+7% +$55.9K 0.11% 179
2021
Q3
$844K Sell
3,971
-153
-4% -$35.2K 0.12% 181
2021
Q2
$1M Sell
4,124
-503
-11% -$124K 0.15% 148
2021
Q1
$1.15M Sell
4,627
-200
-4% -$47.7K 0.21% 95
2020
Q4
$1.11M Buy
4,827
+235
+5% +$54.2K 0.24% 79
2020
Q3
$1.17M Buy
4,592
+322
+8% +$79.8K 0.38% 55
2020
Q2
$1.01M Sell
4,270
-114
-3% -$26K 0.38% 62
2020
Q1
$889K Sell
4,384
-72
-2% -$15.7K 0.47% 57
2019
Q4
$1.07M Buy
4,456
+207
+5% +$45.6K 0.44% 70
2019
Q3
$822K Buy
4,249
+613
+17% +$118K 0.51% 59
2019
Q2
$670K Buy
3,636
+241
+7% +$43.2K 0.43% 73
2019
Q1
$645K Buy
3,395
+281
+9% +$53.7K 0.49% 69
2018
Q4
$606K Buy
3,114
+40
+1% +$7.8K 0.58% 55
2018
Q3
$637K Buy
3,074
+511
+20% +$101K 0.47% 71
2018
Q2
$473K Sell
2,563
-81
-3% -$14.3K 0.41% 83
2018
Q1
$451K Buy
2,644
+721
+37% +$132K 0.43% 80
2017
Q4
$334K Sell
1,923
-11
-0.6% -$1.95K 0.35% 115
2017
Q3
$361K Sell
1,934
-8,339
-81% -$1.48M 0.45% 89
2017
Q2
$1.77M Buy
+10,273
New +$1.67M 0.55% 47

Other funds holding AMGN

StoneX Group's AMGN Position: Q1 2026 in Review

StoneX Group reduced its Amgen (AMGN) stake by 38% in Q1 2026, selling an estimated $2.45M and leaving 11,188 shares worth $3.94M. The position accounts for 0.21% of the portfolio, ranked #82.

StoneX Group first reported a position in AMGN in Q2 2017 and has held it in 27 quarters since. The position peaked at $5.91M in Q4 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • StoneX Group held 11,188 shares of Amgen worth $3.94M as of Q1 2026.
  • StoneX Group sold 6,876 Amgen shares in Q1 2026, an estimated $2.45M.
  • Amgen made up 0.21% of StoneX Group's portfolio in Q1 2026, its #82 holding.
  • StoneX Group first reported a position in Amgen in Q2 2017 and has held it in 27 quarters since.
  • StoneX Group's Amgen position peaked at $5.91M in Q4 2025.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.